Rigel Pharmaceuticals Inc
RIGL· Nasdaq
Released Nov 1, 2011, before the open
10-Q filed Nov 1, 2011, 32 days after period end · 0001104659-11-059341
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| EPS Diluted | -$0.25 | $0.96 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
ended Sep 30, 2011 · filed Nov 1, 2011 · 32 d after period end
2.0% from the close of Oct 31, 2011 to the close of Nov 3, 2011, the first after the release.